IFI-M · HAS Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-00784 // MULTI-AXIS · IFI-M

HAS Tri-Axis Dominant-Primary Series II-IV

Capsicum chinense

Habanero

Tier IIHAS Tri-Axis Dominant-Primary Series

Target Trait

1.52×

fold-change

Heat-dominant tri-axis A+S modulated fold-change

Technical Specifications

SKU

SS-F-M3-00784

Genomic Edits

8

GC Content

44.3%

Construct Length

5,110 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPV1 + Polyphenol-astringency axis + TAS1R2/TAS1R3

IFI Score

152

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HAS pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HAS triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, Polyphenol-astringency axis, and TAS1R2/TAS1R3 pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HAS) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II HAS triple-axis construct for advanced multi-modal sensory architecture combining heat, astringency, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$699 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities